Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)
Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This project proposes to use bronchoscopic intratumoral chemotherapy for small cell lung
cancer in two fashions:
1. to implement a prospective clinical trial to test the feasibility and efficacy of
intralesional chemotherapy as consolidative therapy immediately following standard
systemic chemotherapy and radiation therapy for patients with limited stage SCLC by
comparing tumor growth and survival rates of the treatment group and compare the
outcomes to historical controls
2. to implement a prospective clinical trial to test the feasibility and efficacy as
measured by tumor growth and survival rates of intralesional chemotherapy for patients
with recurrent SCLC after standard treatment.